Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC

NCT07172386 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma (RCC)

Interventions

DRUG: Toripalimab and axitinib

Sponsor

Tianjin Medical University Second Hospital